Alnylam Pharmaceuticals
ALNY
#563
Rank
โ‚ฌ36.52 B
Marketcap
275,39ย โ‚ฌ
Share price
-0.47%
Change (1 day)
23.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company